Corteva/$CTVA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Corteva
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Ticker
$CTVA
Sector
Primary listing
NYSE
Industry
Chemicals
Headquarters
Employees
22,000
ISIN
US22052L1044
Website
Corteva Metrics
BasicAdvanced
$51B
45.13
$1.65
0.72
$0.68
0.91%
Price and volume
Market cap
$51B
Beta
0.72
52-week high
$75.05
52-week low
$50.30
Average daily volume
4.3M
Dividend rate
$0.68
Financial strength
Current ratio
1.445
Quick ratio
0.9
Long term debt to equity
7.306
Total debt to equity
16.647
Dividend payout ratio (TTM)
40.53%
Interest coverage (TTM)
9.13%
Profitability
EBITDA (TTM)
3,328
Gross margin (TTM)
44.63%
Net profit margin (TTM)
6.77%
Operating margin (TTM)
12.37%
Effective tax rate (TTM)
26.82%
Revenue per employee (TTM)
$770,000
Management effectiveness
Return on assets (TTM)
3.08%
Return on equity (TTM)
4.66%
Valuation
Price to earnings (TTM)
45.128
Price to revenue (TTM)
3.049
Price to book
2.09
Price to tangible book (TTM)
9.71
Price to free cash flow (TTM)
24.413
Free cash flow yield (TTM)
4.10%
Free cash flow per share (TTM)
304.71%
Dividend yield (TTM)
0.91%
Forward dividend yield
0.91%
Growth
Revenue change (TTM)
-0.01%
Earnings per share change (TTM)
109.57%
3-year revenue growth (CAGR)
1.54%
3-year earnings per share growth (CAGR)
-11.06%
3-year dividend per share growth (CAGR)
6.69%
What the Analysts think about Corteva
Analyst ratings (Buy, Hold, Sell) for Corteva stock.
Bulls say / Bears say
Corteva's first-quarter 2025 adjusted operating profit exceeded expectations at $1.13 per share, driven by a 3% increase in seed prices, particularly in North America. (reuters.com)
The company introduced Forcivo™ fungicide in June 2025, offering triple-action foliar disease control for crops like corn and soybeans, potentially enhancing its product portfolio and market share. (corteva.us)
Corteva's strategic acquisitions of Stoller Group and Symborg in 2023 have bolstered its position in the biologicals market, aligning with the growing demand for sustainable agricultural solutions. (prnewswire.com)
In the third quarter of 2024, Corteva reported a larger-than-expected loss, with net sales declining 10% to $2.33 billion, leading to a downward revision of its full-year sales forecast. (reuters.com)
The strengthening U.S. dollar poses a significant headwind for Corteva, as it reduces the value of sales generated in foreign currencies, particularly impacting regions like Latin America. (monexa.ai)
Corteva's 2025 earnings forecast of $2.70 to $2.95 per share fell short of analysts' expectations of $3.13, leading to a share price decline of over 4% after the announcement. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.
Corteva Financial Performance
Revenues and expenses
Corteva Earnings Performance
Company profitability
Corteva News
AllArticlesVideos

Micropep and Corteva Announce Multi-Year Research Collaboration to Advance Sustainable Biocontrol Solutions
Business Wire·2 weeks ago

The materials sector is set for a broad breakout, says BTIG's Jonathan Krinsky
CNBC Television·4 weeks ago

Mark Cuban Foundation and Corteva Bring Free AI Bootcamp to Indianapolis, Des Moines Area Teens
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Corteva stock?
Corteva (CTVA) has a market cap of $51B as of July 01, 2025.
What is the P/E ratio for Corteva stock?
The price to earnings (P/E) ratio for Corteva (CTVA) stock is 45.13 as of July 01, 2025.
Does Corteva stock pay dividends?
Yes, the Corteva (CTVA) stock pays dividends to shareholders. As of July 01, 2025, the dividend rate is $0.68 and the yield is 0.91%. Corteva has a payout ratio of 40.53% on a trailing twelve-month basis.
When is the next Corteva dividend payment date?
The next Corteva (CTVA) dividend payment date is unconfirmed.
What is the beta indicator for Corteva?
Corteva (CTVA) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.